Foley & Lardner LLP partner Geoffrey Goodman is quoted in the Fortune article, “Crypto lender Cred collapsed in 2020 after pulling in $135 million from customers. Its shady dealings foreshadowed FTX’s downfall—but regulators didn’t notice.”
Goodman, who co-chairs Foley’s Bankruptcy & Business Reorganization Practice Group, described Cred’s bankruptcy as a “hybrid” of multiple high-profile crypto bankruptcy cases.
“You had customers entrusting money to Cred that they believed was safe,” he explained, as Cred claimed to act like a “broker dealer or a Futures Commission merchant or a bank.” Instead, Goodman added, the money went in some cases to “unsavory charactors, [or] insiders absconding with [it].”
(Subscription required)
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”